The Vancouver Whitecaps confirmed on Friday that center back Belal Halbouni had been diagnosed with cancer and announced a contract extension through the 2027–28 MLS season.
Diagnosis
Halbouni was diagnosed with Hodgkin lymphoma, a rare type of blood cancer deriving from the lymphatic system.
Halbouni posted to Instagram: “I never thought I’d be sharing something like this, but unfortunately this is reality and something I need to address. I recently found out I’d been diagnosed with Hodgkin’s Lymphoma, a form of cancer”
Treatment
The 26-year-old Syrian defender had been sidelined for the entire 2026 MLS season with a knee injury. Halbouni had stepped away from the club and begun medical treatment in London, Ontario, his hometown.
Contract and appearances
Halbouni joined the Whitecaps ahead of the 2024 season and had made 29 appearances across all competitions.
Knee injury
He suffered a season-ending left knee bone contusion in the quarterfinals match in which he played.
Club support
Axel Schuster, the Vancouver Whitecaps sporting director, said: “Belal and his family have the full support of everyone at the club. Belal will take time away from football to focus on his treatment and recovery. We will be here for him every step of the way, and we look forward to welcoming him back when the time is right.”
